Ethos Laboratories and Agena BioSciences Announce Strategic Partnership to Streamline SARS-CoV-2 Variant Detection
Share this article Share this article NEWPORT, Ky., April 13, 2021 /PRNewswire/ -- Ethos Laboratories®, a national leader in laboratory testing, has announced a strategic partnership with Agena® Biosciences which will leverage Agena's innovative MassARRAY MALDI-TOF platform for high throughput SARS-CoV-2 variant detection. Next generation sequencing (NGS) technologies have traditionally been employed for variant detection but due to high cost, low sample throughput and the need for extensive bioinformatics, these platforms are not well suited to high throughput testing. Given these shortco...